Global HealthX Crosses USD 15 Mn in Healthcare Investments, Plans USD 8–10 Mn Deployment in 2026 Global HealthX plans USD 8–10 million investment in 10 startups, offering stage-agnostic funding to strengthen India's healthcare infrastructure.
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
Global HealthX, a healthcare and life sciences innovation platform under the Global University Foundation, has crossed USD 15 million in investments across startups and studio-built ventures over the past two years.
The Hyderabad-based organisation now plans to deploy an additional USD 8–10 million in 2026 across 10 more startups in healthcare and life sciences. The proposed investments are aimed at strengthening long-term healthcare infrastructure in India and improving market access for emerging companies.
Global HealthX typically invests between USD 250,000 and USD 500,000 per company. It also provides follow-on funding from pre-seed to Series A and later stages, depending on the startup's scale and potential impact.
The platform operates through an integrated three-pillar model that combines a venture studio, strategic investments and market-access partnerships. Its venture studio co-develops healthcare products and spins them out as independent ventures or licenses them to industry players. The investment arm offers stage-agnostic capital, while the market-access vertical works with hospitals, clinicians, pharmaceutical firms and insurers to support validation and expansion.
Dr Ravindranath Kancherla, Founder and Chairperson of Global HealthX and the Global University Foundation, said, "India's future in healthcare and life sciences depends on our ability to convert research into solutions that work at scale. Global HealthX is designed to bring capital, clinical expertise and execution together to strengthen healthcare delivery and advance health equity—both in India and globally."
The latest cohort includes TapHealth, Wellytics, Monitra Health, Merry Health and Avika, which focus on areas such as AI-led chronic care, cardiac monitoring, emergency response, genomics-based precision medicine and virtual reality therapy for mental health.
Its broader portfolio spans digital health financing, robotics, AI-led screening and VR-based rehabilitation. Two portfolio companies, Makers Hive and CognitiveBotics, have also been selected to work with the UK's National Health Service, highlighting the platform's expanding international presence.
